176 related articles for article (PubMed ID: 30758703)
21. Visualization of Breast Cancer Metabolism Using Multimodal Nonlinear Optical Microscopy of Cellular Lipids and Redox State.
Hou J; Williams J; Botvinick EL; Potma EO; Tromberg BJ
Cancer Res; 2018 May; 78(10):2503-2512. PubMed ID: 29535219
[TBL] [Abstract][Full Text] [Related]
22. Role of the DEK oncogene in the development of squamous cell carcinoma.
Ishida K; Nakashima T; Shibata T; Hara A; Tomita H
Int J Clin Oncol; 2020 Sep; 25(9):1563-1569. PubMed ID: 32656741
[TBL] [Abstract][Full Text] [Related]
23. Optical Redox Imaging of Treatment Responses to Nampt Inhibition and Combination Therapy in Triple-Negative Breast Cancer Cells.
Podsednik A; Jiang J; Jacob A; Li LZ; Xu HN
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070254
[TBL] [Abstract][Full Text] [Related]
24. The DEK oncogene promotes cellular proliferation through paracrine Wnt signaling in Ron receptor-positive breast cancers.
Privette Vinnedge LM; Benight NM; Wagh PK; Pease NA; Nashu MA; Serrano-Lopez J; Adams AK; Cancelas JA; Waltz SE; Wells SI
Oncogene; 2015 Apr; 34(18):2325-36. PubMed ID: 24954505
[TBL] [Abstract][Full Text] [Related]
25. Silencing DEK downregulates cervical cancer tumorigenesis and metastasis via the DEK/p-Ser9-GSK-3β/p-Tyr216-GSK-3β/β-catenin axis.
Xu X; Zou L; Yao Q; Zhang Y; Gan L; Tang L
Oncol Rep; 2017 Aug; 38(2):1035-1042. PubMed ID: 28627610
[TBL] [Abstract][Full Text] [Related]
26. Epithelial‑mesenchymal transition in colorectal carcinoma cells is mediated by DEK/IMP3.
You S; Guan Y; Li W
Mol Med Rep; 2018 Jan; 17(1):1065-1070. PubMed ID: 29115492
[TBL] [Abstract][Full Text] [Related]
27. DEK oncogene is overexpressed during melanoma progression.
Riveiro-Falkenbach E; Ruano Y; García-Martín RM; Lora D; Cifdaloz M; Acquadro F; Ballestín C; Ortiz-Romero PL; Soengas MS; Rodríguez-Peralto JL
Pigment Cell Melanoma Res; 2017 Mar; 30(2):194-202. PubMed ID: 27893188
[TBL] [Abstract][Full Text] [Related]
28. Relationship between Optical Redox Status and Reactive Oxygen Species in Cancer Cells.
Podsednik A; Jacob A; Li LZ; Xu HN
React Oxyg Species (Apex); 2020 Mar; 9(26):95-108. PubMed ID: 32066994
[TBL] [Abstract][Full Text] [Related]
29. Quantitative redox imaging biomarkers for studying tissue metabolic state and its heterogeneity.
Xu HN; Li LZ
J Innov Opt Health Sci; 2014 Mar; 7(2):. PubMed ID: 31827630
[TBL] [Abstract][Full Text] [Related]
30. The miR-1204 regulates apoptosis in NSCLC cells by targeting DEK.
Qian Z; Yang J; Liu H; Yin Y; Hou L; Hu H
Folia Histochem Cytobiol; 2019; 57(2):64-73. PubMed ID: 31246264
[TBL] [Abstract][Full Text] [Related]
31. DEK modulates both expression and alternative splicing of cancer‑related genes.
Liu B; Sun Y; Zhang Y; Xing Y; Suo J
Oncol Rep; 2022 Jun; 47(6):. PubMed ID: 35475534
[TBL] [Abstract][Full Text] [Related]
32. Optical redox imaging indices discriminate human breast cancer from normal tissues.
Xu HN; Tchou J; Feng M; Zhao H; Li LZ
J Biomed Opt; 2016 Nov; 21(11):114003. PubMed ID: 27896360
[TBL] [Abstract][Full Text] [Related]
33. Imaging Redox State in Mouse Muscles of Different Ages.
Moon L; Frederick DW; Baur JA; Li LZ
Adv Exp Med Biol; 2017; 977():51-57. PubMed ID: 28685427
[TBL] [Abstract][Full Text] [Related]
34. Promotion of cell proliferation by the proto-oncogene DEK enhances oral squamous cell carcinogenesis through field cancerization.
Nakashima T; Tomita H; Hirata A; Ishida K; Hisamatsu K; Hatano Y; Kanayama T; Niwa A; Noguchi K; Kato K; Miyazaki T; Tanaka T; Shibata T; Hara A
Cancer Med; 2017 Oct; 6(10):2424-2439. PubMed ID: 28834425
[TBL] [Abstract][Full Text] [Related]
35. Optical redox ratio identifies metastatic potential-dependent changes in breast cancer cell metabolism.
Alhallak K; Rebello LG; Muldoon TJ; Quinn KP; Rajaram N
Biomed Opt Express; 2016 Nov; 7(11):4364-4374. PubMed ID: 27895979
[TBL] [Abstract][Full Text] [Related]
36. Role of DEK in carcinogenesis, diagnosis, prognosis, and therapeutic outcome of breast cancer: An evidence-based clinical review.
Habiburrahman M; Sutopo S; Wardoyo MP
Crit Rev Oncol Hematol; 2023 Jan; 181():103897. PubMed ID: 36535490
[TBL] [Abstract][Full Text] [Related]
37. The oncoprotein DEK affects the outcome of PARP1/2 inhibition during mild replication stress.
Ganz M; Vogel C; Czada C; Jörke V; Gwosch EC; Kleiner R; Pierzynska-Mach A; Zanacchi FC; Diaspro A; Kappes F; Bürkle A; Ferrando-May E
PLoS One; 2019; 14(8):e0213130. PubMed ID: 31408463
[TBL] [Abstract][Full Text] [Related]
38. NMR-based metabolomic analysis identifies RON-DEK-β-catenin dependent metabolic pathways and a gene signature that stratifies breast cancer patient survival.
Vicente-Muñoz S; Hunt BG; Lange TE; Wells SI; Waltz SE
PLoS One; 2022; 17(9):e0274128. PubMed ID: 36067206
[TBL] [Abstract][Full Text] [Related]
39. Spectroscopic Study of Time-Varying Optical Redox Ratio in NADH/FAD Solution.
Lim SY; Jang JI; Yoon H; Kim HM
J Phys Chem B; 2022 Dec; 126(47):9840-9849. PubMed ID: 36399328
[TBL] [Abstract][Full Text] [Related]
40. Heterogeneity of mitochondrial redox state in premalignant pancreas in a PTEN null transgenic mouse model.
Xu HN; Nioka S; Chance B; Li LZ
Adv Exp Med Biol; 2011; 701():207-13. PubMed ID: 21445789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
